Circulating Tumor DNA Is a Prognostic Marker of Tumor Recurrence in Stage II and III Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)
Eur. J. Cancer 2021 Dec 01;159(xx)24-33, L Benhaim, O Bouché, C Normand, A Didelot, C Mulot, D Le Corre, S Garrigou, J Djadi-Prat, SF Wang-Renault, K Perez-Toralla, D Pekin, G Poulet, B Landi, J Taieb, M Selvy, JF Emile, T Lecomte, H Blons, G Chatellier, DR Link, V Taly, P Laurent-PuigFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.